Integral Diagnostics Limited (ASX:IDX – Get Free Report) insider Kevin (Kai-Chung) Shaw purchased 28,000 shares of Integral Diagnostics stock in a transaction that occurred on Friday, February 27th. The stock was acquired at an average cost of A$2.43 per share, with a total value of A$68,040.00.
Integral Diagnostics Price Performance
The company has a debt-to-equity ratio of 124.07, a current ratio of 0.63 and a quick ratio of 1.84. The stock has a market cap of $880.11 million, a P/E ratio of 63.24, a P/E/G ratio of 1.39 and a beta of 0.14.
Integral Diagnostics Dividend Announcement
The business also recently disclosed a Interim dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Wednesday, April 1st will be given a dividend of $0.033 per share. The ex-dividend date is Tuesday, March 3rd. This represents a yield of 137.0%. Integral Diagnostics’s dividend payout ratio is currently -28.08%.
About Integral Diagnostics
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
Further Reading
- Five stocks we like better than Integral Diagnostics
- Is Elon Preparing for a Silver Shock?
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- Your name isn’t on our protected list yet
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Integral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
